We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SB icon
451
Safe Bulkers
SB
$774M
$108K 0.05%
30,005
-23,135
-44% -$82.8K
ZVRA icon
452
Zevra Therapeutics
ZVRA
$686M
$108K 0.05%
+12,217
New +$99.1K
BLND icon
453
Blend Labs
BLND
$386M
$108K 0.05%
32,606
-4,944
-13% -$16.8K
KURA icon
454
Kura Oncology
KURA
$850M
$107K 0.05%
18,619
-21,405
-53% -$131K
LXP icon
455
LXP Industrial Trust
LXP
$3.57B
$107K 0.05%
2,582
-466
-15% -$19.2K
ASLE icon
456
AerSale
ASLE
$279M
$106K 0.05%
17,598
-8,622
-33% -$55.2K
CDE icon
457
Coeur Mining
CDE
$17.9B
$104K 0.05%
+11,770
New +$85.7K
CAPR icon
458
Capricor Therapeutics
CAPR
$237M
$104K 0.05%
+10,472
New +$111K
AHCO icon
459
AdaptHealth
AHCO
$759M
$103K 0.04%
10,946
-25,203
-70% -$222K
VREX icon
460
Varex Imaging
VREX
$523M
$101K 0.04%
+11,644
New +$95K
CYRX icon
461
CryoPort
CYRX
$762M
$101K 0.04%
+13,481
New +$83.7K
REPL icon
462
Replimune Group
REPL
$1.01B
$99.7K 0.04%
+10,735
New +$93.7K
GLUE icon
463
Monte Rosa Therapeutics
GLUE
$1.35B
$98.6K 0.04%
+21,867
New +$97.5K
CTOS icon
464
Custom Truck One Source
CTOS
$2.37B
$95.9K 0.04%
19,408
+6,887
+55% +$29.7K
FF icon
465
Future Fuel
FF
$223M
$95.4K 0.04%
24,597
-15,918
-39% -$64K
ENTA icon
466
Enanta Pharmaceuticals
ENTA
$400M
$94.8K 0.04%
12,538
-8,437
-40% -$50.8K
ALTG icon
467
Alta Equipment Group
ALTG
$245M
$94.5K 0.04%
14,954
-8,520
-36% -$43.1K
DRH icon
468
Diamondrock Hospitality Co
DRH
$2.56B
$94.1K 0.04%
+12,289
New +$91.7K
COGT icon
469
Cogent Biosciences
COGT
$7.24B
$93.6K 0.04%
+13,038
New +$72.3K
NPKI
470
NPK International
NPKI
$1.14B
$92.4K 0.04%
+10,861
New +$79.6K
UDMY
471
DELISTED
Udemy
UDMY
$90.3K 0.04%
12,848
-4,138
-24% -$28.5K
MDXG icon
472
MiMedx Group
MDXG
$633M
$88.4K 0.04%
+14,463
New +$96.2K
LION icon
473
Lionsgate Studios
LION
$3.86B
$87.3K 0.04%
+15,030
New +$101K
CFFN icon
474
Capitol Federal Financial
CFFN
$1.1B
$87.1K 0.04%
14,283
+2,028
+17% +$11.5K
COMP icon
475
Compass
COMP
$9.66B
$86K 0.04%
+13,694
New +$93.8K
17 18
19
20 21

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.